AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 102 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $123,000 | -39.1% | 196,954 | -17.6% | 0.00% | – |
Q3 2019 | $202,000 | +66.9% | 239,006 | +33.0% | 0.00% | – |
Q2 2019 | $121,000 | -44.0% | 179,716 | -31.8% | 0.00% | – |
Q1 2019 | $216,000 | -46.5% | 263,355 | +4.3% | 0.00% | – |
Q4 2018 | $404,000 | -37.5% | 252,415 | +29.3% | 0.00% | – |
Q3 2018 | $646,000 | +129.9% | 195,143 | +56.8% | 0.00% | – |
Q2 2018 | $281,000 | -14.8% | 124,465 | +9.3% | 0.00% | – |
Q1 2018 | $330,000 | +10.7% | 113,892 | +6.8% | 0.00% | – |
Q4 2017 | $298,000 | – | 106,637 | +13229.6% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 800 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | -50.0% | 800 | -50.0% | 0.00% | – |
Q1 2015 | $2,000 | +100.0% | 1,600 | +100.0% | 0.00% | – |
Q4 2014 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q4 2013 | $1,000 | -50.0% | 800 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q2 2013 | $2,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |